  Multivalent virus binding inhibitors are a promising new class of antivirals,
preventing virus infection of cells by inhibiting the first step in the viral
infection cycle - binding of viruses to the cell surface. The design of
multivalent virus binding inhibitors is complex as many properties, such as
inhibitor size and functionalization with virus attachment factors, have a
strong impact on the inhibition efficiency. In this study, we synthesized virus
binding inhibitors, the design of which has been inspired by mucins, which are
naturally occurring glycosylated proteins with molecular weights in the MDa
range and which show high affinity in the interaction with various viruses.
Hyperbranched polyglycerols (hPG), serving as polymeric scaffolds, were
functionalized with sialic acids and sulfate groups at degrees of
functionalization as suggested from the structure of mucins. The molecular
weights of the hPG-based inhibitors ranged between 10 and 2600 kDa, thereby
hitting the size of mucins (MDa scale) and allowing for comparing the
inhibition efficiency of the largest, mucin-sized inhibitor (2600 kDa) with
related inhibitors of lower molecular weight. Inhibition efficiencies were
determined by various methods based on the inhibition of influenza A virus
(IAV) binding to lipid membranes, including an assay based on total internal
reflection fluorescence (TIRF) microscopy that allows for probing the
interaction of IAV with its native attachment factor, sialic acid. Potent
inhibition is observed in all assays already at pM concentrations for the
mucin-sized inhibitor, while decreasing the inhibitor's molecular weight also
decreased its inhibition efficiency. In addition, a biphasic binding behavior
of the inhibitors to IAV is observed, which is attributed to differences in the
binding affinity to two IAV envelope proteins, neuraminidase and hemagglutinin.
